Waters shareholders approve BD Biosciences combination; close expected Feb 9, 2026

WATERS CORP /DE/

Approximately 99% of shares present at special meeting voted to approve share issuance for BD Biosciences deal.
Transaction expected to close on February 9, 2026, subject to remaining customary conditions.
IRS private letter ruling on tax consequences received; all required regulatory approvals secured.
Waters Q4 2025 earnings release and conference call rescheduled to February 9, 2026, in conjunction with close.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.